This is a StreetInsider.com Premium Only Page

Ocular Therapeutix (OCUL) – Trader Talk

Sep 27, 2022 09:14 AM UPDATE: Ocular Therapeutix (OCUL) Falls 14% After Reporting Interim 7-month Data from Phase 1 Clinical Trial of OTX-TKI

May 19, 2021 08:26 AM Companies with NDRs 5/19

Jul 18, 2017 04:59 AM

Jul 13, 2017 11:15 AM

Jul 7, 2017 03:29 PM

Oct 13, 2016 08:38 AM

Oct 13, 2016 07:01 AM

Aug 5, 2016 10:36 AM

Aug 4, 2016 09:14 AM

Feb 17, 2016 08:48 AM

Apr 6, 2015 04:31 PM